3rd Annual CKD3 Summit
Evvnt Promotion / evvnt
Archiv
02.03.2021 - 04.03.2021 Online
Time: 10:00 - 17:00
Kongressthemen
Overcome the translational challenges limiting the development of the next generation of CKD therapeutics. For the 3rd year, the Chronic Kidney Disease Drug Development Summit (CKD3) is putting the hottest topics in CKD drug development under the spotlight.
Overcome the translational challenges limiting the development of the next generation of CKD therapeutics. For the 3rd year, the Chronic Kidney Disease Drug Development Summit (CKD3) is putting the hottest topics in CKD drug development under the spotlight.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/613460-3?pid=4832
Speakers: Andrew King, Head of Renal Discovery and Translational Medicine, Chinook Therapeutics, Beno Freedman, Assistant Professor, Nephrology, University of Washington and more.
URL:
Brochure: https://go.evvnt.com/613460-3?pid=4832
Speakers: Andrew King, Head of Renal Discovery and Translational Medicine, Chinook Therapeutics, Beno Freedman, Assistant Professor, Nephrology, University of Washington and more.
Anfragen und Anmeldung:
https://go.evvnt.com/613460-2?pid=4832
Herr Customer Service
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 420.0 - USD 2720.0
USD 420.0 - USD 2720.0
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
